HK1149719A1 - Ciclesonide contained pharmaceutical composition for application to mucosa - Google Patents

Ciclesonide contained pharmaceutical composition for application to mucosa

Info

Publication number
HK1149719A1
HK1149719A1 HK11104081.9A HK11104081A HK1149719A1 HK 1149719 A1 HK1149719 A1 HK 1149719A1 HK 11104081 A HK11104081 A HK 11104081A HK 1149719 A1 HK1149719 A1 HK 1149719A1
Authority
HK
Hong Kong
Prior art keywords
mucosa
application
pharmaceutical composition
contained pharmaceutical
ciclesonide
Prior art date
Application number
HK11104081.9A
Other languages
English (en)
Inventor
Atsuhiro Nagano
Yoshihisa Nishibe
Kazuya Takanashi
Original Assignee
Takeda Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856327&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1149719(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Gmbh filed Critical Takeda Gmbh
Publication of HK1149719A1 publication Critical patent/HK1149719A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK11104081.9A 1999-10-20 2011-04-21 Ciclesonide contained pharmaceutical composition for application to mucosa HK1149719A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29818599 1999-10-20

Publications (1)

Publication Number Publication Date
HK1149719A1 true HK1149719A1 (en) 2011-10-14

Family

ID=17856327

Family Applications (2)

Application Number Title Priority Date Filing Date
HK03103180.1A HK1050858A1 (zh) 1999-10-20 2003-05-05 應用於粘膜的含環索奈德藥用組合物
HK11104081.9A HK1149719A1 (en) 1999-10-20 2011-04-21 Ciclesonide contained pharmaceutical composition for application to mucosa

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK03103180.1A HK1050858A1 (zh) 1999-10-20 2003-05-05 應用於粘膜的含環索奈德藥用組合物

Country Status (36)

Country Link
US (1) US6767901B1 (xx)
EP (1) EP1225902B1 (xx)
JP (1) JP4264211B2 (xx)
KR (1) KR100722209B1 (xx)
CN (2) CN1379674B (xx)
AR (1) AR026072A1 (xx)
AT (1) ATE285779T1 (xx)
AU (1) AU781895B2 (xx)
BG (1) BG65818B1 (xx)
BR (1) BRPI0014878B8 (xx)
CA (1) CA2388322C (xx)
CO (1) CO5261494A1 (xx)
CZ (1) CZ297779B6 (xx)
DE (1) DE60017175T2 (xx)
DK (1) DK1225902T3 (xx)
EA (1) EA006015B1 (xx)
ES (1) ES2234681T3 (xx)
HK (2) HK1050858A1 (xx)
HR (1) HRP20020346B1 (xx)
HU (1) HU228893B1 (xx)
IL (2) IL148691A0 (xx)
ME (1) ME00567A (xx)
MX (1) MXPA02003974A (xx)
MY (1) MY136987A (xx)
NO (1) NO327444B1 (xx)
NZ (1) NZ518298A (xx)
PE (1) PE20010712A1 (xx)
PL (1) PL199702B1 (xx)
PT (1) PT1225902E (xx)
RS (1) RS50310B (xx)
SI (1) SI1225902T1 (xx)
SK (1) SK286196B6 (xx)
TR (1) TR200200841T2 (xx)
TW (1) TWI225788B (xx)
WO (1) WO2001028562A1 (xx)
ZA (1) ZA200203077B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
NZ537945A (en) * 2002-07-02 2007-08-31 Altana Pharma Ag Ciclesonide-containing sterile aqueous suspension
US7221586B2 (en) 2002-07-08 2007-05-22 Micron Technology, Inc. Memory utilizing oxide nanolaminates
CN100509852C (zh) * 2002-07-26 2009-07-08 Fmc有限公司 微晶纤维素的制造
KR101067795B1 (ko) * 2002-08-30 2011-09-27 니코메드 게엠베하 알레르기성 비염을 치료하기 위한 사이클레소나이드 및 항히스타민제의 조합물의 용도
DK1572217T3 (da) * 2002-12-12 2008-12-15 Nycomed Gmbh Kombinationsmedikament af R,R-formoterol og ciclesonid
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
US8371292B2 (en) * 2003-09-16 2013-02-12 Nycomed Gmbh Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070134165A1 (en) * 2004-04-20 2007-06-14 Altana Pharma Ag Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient
JP2008512428A (ja) * 2004-09-10 2008-04-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング シクレソニドとＳｙｋインヒビターとの組合せ物並びにその使用方法
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
WO2009114192A2 (en) * 2008-03-14 2009-09-17 Cephalon, Inc. Enhanced transmucosal composition and dosage form
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63303931A (ja) * 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
GB9103824D0 (en) * 1991-02-23 1991-04-10 Fisons Ag Formulation
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
EP1050299A4 (en) 1998-01-22 2007-05-02 Santen Pharmaceutical Co Ltd SUSPENSION COLLYRE OF FLUOROMETHOLONE
SE514128C2 (sv) 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa

Also Published As

Publication number Publication date
BRPI0014878B8 (pt) 2021-05-25
PE20010712A1 (es) 2001-07-12
MXPA02003974A (es) 2003-09-25
CZ297779B6 (cs) 2007-03-28
ES2234681T3 (es) 2005-07-01
CN101869570A (zh) 2010-10-27
BR0014878A (pt) 2002-06-11
CZ20021238A3 (cs) 2002-07-17
BRPI0014878B1 (pt) 2015-08-11
EP1225902B1 (en) 2004-12-29
ME00567B (me) 2011-12-20
CA2388322A1 (en) 2001-04-26
DE60017175T2 (de) 2005-12-29
HU228893B1 (hu) 2013-06-28
TWI225788B (en) 2005-01-01
IL148691A (en) 2006-12-10
ZA200203077B (en) 2003-02-26
RS50310B (sr) 2009-09-08
IL148691A0 (en) 2002-09-12
KR100722209B1 (ko) 2007-05-29
PL356191A1 (en) 2004-06-14
TR200200841T2 (tr) 2002-07-22
DE60017175D1 (de) 2005-02-03
SK286196B6 (sk) 2008-05-06
NZ518298A (en) 2003-11-28
NO20021898L (no) 2002-04-22
AU7953100A (en) 2001-04-30
YU28002A (sh) 2004-11-25
HUP0203339A2 (hu) 2003-02-28
BG106512A (bg) 2002-12-29
ATE285779T1 (de) 2005-01-15
SK6922002A3 (en) 2002-09-10
CN101869570B (zh) 2012-10-10
HRP20020346A2 (en) 2004-02-29
ME00567A (en) 2011-12-20
HK1050858A1 (zh) 2003-07-11
NO20021898D0 (no) 2002-04-22
JP2003512329A (ja) 2003-04-02
CO5261494A1 (es) 2003-03-31
WO2001028562A1 (en) 2001-04-26
CN1379674A (zh) 2002-11-13
DK1225902T3 (da) 2005-05-02
KR20020059627A (ko) 2002-07-13
AU781895B2 (en) 2005-06-23
HRP20020346B1 (en) 2011-06-30
MY136987A (en) 2008-12-31
AR026072A1 (es) 2002-12-26
JP4264211B2 (ja) 2009-05-13
SI1225902T1 (en) 2005-06-30
PT1225902E (pt) 2005-05-31
NO327444B1 (no) 2009-06-29
CN1379674B (zh) 2014-10-29
EA006015B1 (ru) 2005-08-25
PL199702B1 (pl) 2008-10-31
HUP0203339A3 (en) 2004-07-28
US6767901B1 (en) 2004-07-27
BG65818B1 (bg) 2010-01-29
EP1225902A1 (en) 2002-07-31
CA2388322C (en) 2007-09-18
EA200200375A1 (ru) 2002-10-31

Similar Documents

Publication Publication Date Title
HK1149719A1 (en) Ciclesonide contained pharmaceutical composition for application to mucosa
HUP0002512A3 (en) Medicinal compositions for application to mucosa
HUP0200879A3 (en) Pharmaceutical composition for dermal use
HUP0204372A3 (en) Pharmaceutical compositions providing enhanced drug concentrations
HUP0202513A2 (en) Betha-carboline pharmaceutical compositions
HUP0201376A2 (en) Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
GB0028088D0 (en) Pharmaceutical compositions
HUP0202495A3 (en) Stable medicinal compositions for oral use
GB0001662D0 (en) Pharmaceutical compositions
HUP0203311A3 (en) New pharmaceutical compositions of prolonged effect
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
GB9904163D0 (en) Pharmaceutical compositions
HUP0200747A2 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
GB9911017D0 (en) Pharmaceutical compositions
IL149422A0 (en) Oral pharmaceutical compositions for liver therapy
GB9904911D0 (en) Pharmaceutical compositions
HUP0200311A3 (en) Use of aroyl- or arylalkanoylpyridazines for preparation of pharmaceutical compositions
GB9902227D0 (en) Pharmaceutical composition for topical administration
EP1210935A4 (en) DRUGS FOR ORAL USE
IL149470A0 (en) Pharmaceutical compositions containing carboxamidoadenosine derivatives
GB9902651D0 (en) Pharmaceutical compositions
EP1188440A4 (en) MEDICINAL COMPOSITION FOR ORAL ADMINISTRATION
GB9916210D0 (en) Pharmaceutical composition
GB9916413D0 (en) Pharmaceutical composition
GB9908636D0 (en) Novel pharmaceutical composition

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20201019